scholarly journals Determination of Red Cell Indices and Sero-prevalence of Transfusion Transmissible Infectious Diseases among Stable Paediatric Sickle Cell Patients

2021 ◽  
Vol 8 (1) ◽  
pp. 1-5
Author(s):  
Esan Ayodele Jacob ◽  

Red blood cell indices values were lower compared with control subjects, nature has it that SCD patients in the steady state have adapted their body system to this anaemic state and live healthy. Blood transfusion does not significantly increase the seroprevalence of transfusion transmissible infections in our clinically stable SCD participants.

Blood ◽  
2014 ◽  
Vol 124 (21) ◽  
pp. 4045-4045
Author(s):  
Greg Hapgood ◽  
Timothy Walsh ◽  
Ronit Cukierman ◽  
Eldho Paul ◽  
Ken Cheng ◽  
...  

Abstract Background: β thalassemia major results in ineffective erythropoiesis. Blood transfusion aims, in part, to suppress this and to limit morbidity from anaemia, bone marrow expansion and extra-medullary hemopoiesis (EMH), thereby increasing survival. According to current international guidelines, males and females are transfused equally. Aims: We sought to assess the adequacy of suppression of erythropoiesis in all 126 transfused adult (>18 years) males and females with β thalassemia major at our centre by: (1) assessing readily available pre-transfusion indices of erythropoiesis, including erythropoietin (EPO) levels; (2) determining the volume of blood transfused per kilogram (kg) and per calculated blood volume; and (3) assessing the incidence of para-spinal EMH masses based on magnetic resonance imaging (MRI). Methods: We analysed pre-transfusion (i.e., the day of transfusion) hemoglobin (Hb), reticulocyte count, red blood cell count (RCC), nucleated red blood cell (NRBC) count, EPO and ferritin levels in patients receiving stable, regular blood transfusion. Automated and manual NRBC and reticulocyte enumerations were performed. Blood volume was calculated using Nadler’s formula. MRI performed to assess cardiac function and hepatic and cardiac iron loading was reviewed for the presence of para-spinal EMH. Results: One hundred and sixteen adult patients (51 males and 65 females) provided pre-transfusion blood samples (Table 1). The 10 patients not included were either not available or declined testing. The mean pre-transfusion Hb was 98-99g/l with no difference between males or females (Table 2). Therefore, our data reflect long-standing adherence to current international transfusion recommendations. EPO levels and NRBC count (manual and automated) were significantly higher in males compared to females. RCC, reticulocyte count (manual and automated) and ferritin levels were not different between males and females. Males received less blood per kg of body weight and per calculated blood volume. The incidence of para-spinal EMH was 13% (14/110) and was significantly higher in males (11/50) compared to females (3/60)(22% versus 5%, respectively, (p = 0.01)). The incidence of splenectomy was higher in males. Conclusions: These findings confirm that erythropoiesis is not equally suppressed in males and females and that males are more prone to complications from being under-transfused with current transfusion practices. This work has major clinical implications for transfusion practices in the management of β thalassemia major. Abstract 4045. Table 1 Summary of patients included in the study Variable Overall Males Females p value Number 116 51 65 - Age (years) 39.3 ± 9.3 40.0 ± 9.6 38.8 ± 9.1 0.511 Weight (kg) 60.0 ± 11.6 64.9 ± 9.8 55.7 ± 12.4 < 0.0001 Height (cm) 159 ± 10.5 166 ± 8.3 153 ± 8.1 < 0.0001 Transfusion interval (weeks) 3.2 ± 0.6 3.2 ± 0.7 3.1 ± 0.5 0.168 No. RBC units per transfusion 3.03 ± 0.63 3.22 ± 0.76 2.89 ± 0.48 0.006 Estimated annual transfused volume (l) 13.5 (10.1-13.5) 14.0 (14.0-14.0) 14.0 (10.0-14.0) < 0.0001 Estimated annual transfused volume per kg (ml/kg) 215 (185-255) 202 (185-225) 225 (188-263) 0.028 Estimated patient blood volume (l) 3.79 ± 0.73 4.39 ± 0.50 3.32 ± 0.52 < 0.0001 Ratio of estimated annual transfused volume (l) per estimated patient blood volume (l) 3.33 (2.84-4.01) 2.98 (2.68-3.28) 3.79 (3.3-4.35) < 0.0001 Splenectomy 49.5% 61% 40% 0.031 Data are mean ± standard deviation, median (interquartile range) or percentage. Transfused volumes are calculated on the assumption that each unit contains 260ml red cells (Australia Red Cross Blood Service red cell unit mean volume = 259 ± 23ml). Nadler’s formula for total blood volume (TBV): men TBV (ml) = 604 + (367 x height3(m3)) + (32.2 x weight (kg)); women TBV = 183 + (356 x height3(m3)) + 33.1 x weight (kg)). Table 2. Laboratory indices of pre-transfusion erythropoiesis for all patients Variable Overall Male Female p value Hemoglobin (g/l) 98 ± 8.9 98 ± 9.9 99 ± 8.1 0.36 Red cell count (x 1012/l) 3.4 ± 0.35 3.45 ± 0.40 3.50 ± 0.32 0.46 Ferritin (mcg/l) 821 (604-1300) 754 (582-1139) 943 (639-1356) 0.11 Erythropoietin (mIU/ml) 58 (37-99) 72 (41-149) 52 (35-89) 0.006 Manual NRBC (number NRBC/100 WBC counted) 6 (1-54) 21 (2-98) 3 (1-28) 0.003 Automated NRBC (number NRBC/100 WBC counted) 5 (0-34) 17 (0-54) 1 (0-20) 0.014 Data are mean ± standard deviation or median (interquartile range). Disclosures No relevant conflicts of interest to declare.


Blood ◽  
1962 ◽  
Vol 20 (6) ◽  
pp. 750-755 ◽  
Author(s):  
ANTONIO ROTTINO ◽  
JOHN W. ANGERS ◽  
Agnes Dool

Abstract 1) A variety of pathologic conditions retard the electrophoretic mobility of the red blood cell. 2) Two retarding factors have been found in the blood serum, one that reduces the mobility of the red cell from normal (1.33µ/cm./sec./volt) to 0.89µ and one that reduces it to 1.14µ. 3) The "0.89" factor and the "1.14" factor can be differentiated and identified. 4) The 0.89-factor has been found in the serum of 99 per cent of patients with cancer and Hodgkin’s disease studied and has been lacking from the serum of all persons with benign tumor. 5) The 0.89-factor has also been found in patients with infectious mononucleosis. 6) A few physical characteristics that enable differentiation of the two slowing factors are described. 7) Clarification of the role played by the 0.89-factor in malignant neoplasm is deemed important. 8) Determination of the presence or absence of the 0.89-factor in the blood serum may become of value in differential diagnosis of malignant neoplasm.


2019 ◽  
Vol 21 (1) ◽  
pp. 1-6
Author(s):  
Sujata Pudasaini ◽  
PP Pant ◽  
N Kafle ◽  
S Maharjan ◽  
A KC ◽  
...  

Anemia is not a disease but a clinical feature of some other underlying problems. It is one of the most common public health problems in developing countries. The prevalence of anemia differs according to the age group. A cross sectional observational study was conducted in a tertiary hospital, over a period of six months (January 2018 to June 2018). All the cases of anemia in different age group with hematological investigations (hemoglobin and red blood cell indices) including reticulocyte count during the study period were included. A total of 274 blood samples of persons with anemia were evaluated. The mean age of the patients was 41.4 ± 25.37 years. Anemia was more commonly seen in females (68.2%) than males (31.8%) in our study. The most affected age group for anemia was person ≥ 15 years followed by children < 5 years. The least affected group was children of 12- 14 years. Microcytic anemia (decreased MCV and decreased MCHC) was observed in children of 12- 14 years and macrocytic anemia (increased MCV) was seen in group ≥ 15 years. Red cell distribution width (RDW) was more elevated in children of 12 -14 years and showed that there was significant variation of size of RBC in this group. Reticulocyte count was higher in children < 5 years and lower in children of 12- 14 years. Significant correlation was noted for hematocrit and reticulocyte count. This study revealed that the prevalence of anemia increases with age and was more common in females. Baseline study of red blood cell indices and reticulocyte count will help us in diagnosing the type of anemia and in further management.


Cells ◽  
2021 ◽  
Vol 10 (4) ◽  
pp. 811
Author(s):  
Camille Boisson ◽  
Minke A. E. Rab ◽  
Elie Nader ◽  
Céline Renoux ◽  
Celeste Kanne ◽  
...  

(1) Background: The aim of the present study was to compare oxygen gradient ektacytometry parameters between sickle cell patients of different genotypes (SS, SC, and S/β+) or under different treatments (hydroxyurea or chronic red blood cell exchange). (2) Methods: Oxygen gradient ektacytometry was performed in 167 adults and children at steady state. In addition, five SS patients had oxygenscan measurements at steady state and during an acute complication requiring hospitalization. (3) Results: Red blood cell (RBC) deformability upon deoxygenation (EImin) and in normoxia (EImax) was increased, and the susceptibility of RBC to sickle upon deoxygenation was decreased in SC patients when compared to untreated SS patients older than 5 years old. SS patients under chronic red blood cell exchange had higher EImin and EImax and lower susceptibility of RBC to sickle upon deoxygenation compared to untreated SS patients, SS patients younger than 5 years old, and hydroxyurea-treated SS and SC patients. The susceptibility of RBC to sickle upon deoxygenation was increased in the five SS patients during acute complication compared to steady state, although the difference between steady state and acute complication was variable from one patient to another. (4) Conclusions: The present study demonstrates that oxygen gradient ektacytometry parameters are affected by sickle cell disease (SCD) genotype and treatment.


1949 ◽  
Vol 7 (2) ◽  
pp. 259
Author(s):  
R.T. Nieset ◽  
Blanche Porter ◽  
W.S. Trautman ◽  
Ralph M. Bell ◽  
William Parson ◽  
...  

1996 ◽  
Vol 13 (01) ◽  
pp. 27-33 ◽  
Author(s):  
Steven Inglis ◽  
Andrzej Lysikiewicz ◽  
Amy Sonnenblick ◽  
Jane Streltzoff ◽  
James Bussel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document